v1
A phase II trial of continuous low-dose oral cyclophosphamide and celecoxib in patients with renal cell carcinoma.
Identifier:nobleid.org/w1/20260515/35AFAC18
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/35AFAC18)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims